INCREASED APOPTOSIS AS THE SIGNIFICANT CAUSE OF INEFFECTIVE HEMATOPOIESIS IN MYELODYSPLASTIC SYNDROMES (MDS)

被引：0
|
作者：
RAZA, A
GREGORY, S
MUNDLE, S
SHETTY, V
ALVI, S
MARCUS, B
LOEW, J
RIFKIN, S
SHOWEL, J
PREISLER, H
机构：
[1] RUSH CANC INST,DEPT PATHOL,CHICAGO,IL
[2] NW COMMUNITY HOSP,CHICAGO,IL
来源：
BLOOD | 1994年 / 84卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A636 / A636
页数：1
相关论文
共 50 条
  • [21] The role of apoptosis, proliferation and amifostine in the myelodysplastic syndromes (MDS) and AML secondary to MDS.
    Parker, JE
    Fishlock, KL
    Pagliuca, A
    Mufti, GJ
    BLOOD, 1998, 92 (10) : 418A - 419A
  • [22] Phase II study of amifostine in patients with myelodysplastic syndromes (MDS): Impact on hematopoiesis.
    List, AF
    Holmes, H
    Vempaty, H
    Greenberg, PL
    Bennett, JM
    BLOOD, 1998, 92 (10) : 714A - 714A
  • [23] Aging, hematopoiesis, and the myelodysplastic syndromes
    Chung, Stephen S.
    Park, Christopher Y.
    BLOOD ADVANCES, 2017, 1 (26) : 2572 - 2578
  • [24] Aging, hematopoiesis, and the myelodysplastic syndromes
    Chung, Stephen S.
    Park, Christopher Y.
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2017, : 73 - 78
  • [25] Assessment of apoptosis in long-term marrow cultures and bone marrow biopsies of myelodysplastic syndromes as the probable basis for ineffective hematopoiesis.
    Hong, DS
    Suh, WS
    Won, JH
    Jeon, JW
    Baick, SH
    Kim, SJ
    Park, HS
    EXPERIMENTAL HEMATOLOGY, 1996, 24 (09) : 572 - 572
  • [26] Update on myelodysplastic syndromes (MDS)
    Hector Rodriguez, Jose
    del Lujan Acosta, Irma
    REVISTA MEDICA DE ROSARIO, 2011, 77 (01): : 24 - 41
  • [27] Rigosertib in myelodysplastic syndromes (MDS)
    Raza, A.
    Ali, A. M.
    Reddy, M. V. R.
    Hoffman, B. S.
    Petrone, M. E.
    Maniar, M.
    Pinheiro, R. F.
    Coutinho, D. F.
    Fruchtman, S. M.
    EXPERT OPINION ON ORPHAN DRUGS, 2016, 4 (09): : 981 - 988
  • [28] The clinical significance or apoptosis in the marrow of patients with primary myelodysplastic syndromes (MDS)
    Kouraklis, A
    Tsoplou, P
    Symeonidis, A
    Orphanos, V
    Zoumbos, N
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 263 - 263
  • [29] Assessment of apoptosis in relation to single cytogenetic abnormalities in myelodysplastic syndromes (MDS).
    Mundle, S
    Hsu, WT
    Dutt, D
    Dar, S
    Saberwal, G
    Townsend, W
    Broderick, E
    Kaspar, C
    Alvi, S
    Shetty, V
    Allampallam, K
    Reddy, P
    Venugopal, P
    Gezer, S
    Lisak, L
    Raza, A
    BLOOD, 2001, 98 (11) : 191B - 191B
  • [30] The pathogenesis of myelodysplastic syndromes (MDS)
    Platzbecker, Uwe
    Meredyth-Stewart, Michelle
    Ehninger, Gerhard
    CANCER TREATMENT REVIEWS, 2007, 33 : S53 - S58
12345